Press "Enter" to skip to content

New patent for Actelion Pharms drug UPTRAVI

0
Copyright © DrugPatentWatch. Originally published at New patent for Actelion Pharms drug UPTRAVI

Annual Drug Patent Expirations for UPTRAVI
Annual Drug Patent Expirations for UPTRAVI

Uptravi is a drug marketed by Actelion Pharms Ltd and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

Drug patent litigation for UPTRAVI.

This drug has ninety-five patent family members in thirty-five countries.

The generic ingredient in UPTRAVI is selexipag. One supplier is listed for this compound. Additional details are available on the selexipag profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Actelion Pharms drug UPTRAVI
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!